Just half of the blood needed for transfusion each year in the African region is collected, leaving many facing life-threatening shortages. The COVID-19 pandemic has further worsened the shortfall, with donations dropping by 17% over the past year.
Blood donation has fallen by 17% in the African region in the wake of the COVID-19 pandemic that has caused widespread disruptions to key health services, lives and livelihoods.
Ethiopia today officially launched a preventive oral cholera vaccination campaign targeting 2 million people aged 1 year and above in Tigray region in the north of the country to avert a potential outbreak
Angola has reached the milestone of more than one million doses of COVID-19 vaccines administered after receiving the first doses from COVAX, a partnership between Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI )and WHO, which aims to ensure equitable distribution of vaccines against COVID-19, worldwide.
As COVID-19 cases in Africa rise for the third week running and vaccines are increasingly scarce, 47 of Africa’s 54 countries—nearly 90%—are set to miss the September target of vaccinating 10% of their people unless Africa receives 225 million more doses.
As the risk of a surge in COVID-19 cases increases, African countries must urgently boost critical care capacity to prevent health facilities from being overwhelmed. This comes as vaccine shipments to the continent grind to a near halt.
Africa needs at least 20 million doses of the Oxford-AstraZeneca vaccine in the next six weeks to get second doses to all who received a first dose within the 8—12-week interval between doses recommended by the World Health Organization (WHO).
Pemba, 21 May 2021 – More than 1.2 million people urgently need health assistance in Cabo Delgado Province in northern Mozambique where recent armed attacks sparked further population displacement and deepened a protracted humanitarian crisis.
A blockage on supplies and financial challenges are delaying Africa’s rollout of COVID-19 vaccines and risk curtailing plans to significantly expand the continent’s rollout later this year.
The WHO Regional Office for Africa wishes to provide clarification and guidance on the issue of expiry dates of COVID-19 vaccines in general, and specifically on AstraZeneca vaccine doses produced by the Serum Institute of India (SII) – referred to as Covishield, that were delivered to several African countries and have since expired
